DESIGN THERAPEUTICS INC's ticker is DSGN and the CUSIP is 25056L103. A total of 75 filers reported holding DESIGN THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,402,483 | -62.5% | 6,526,476 | 0.0% | 7.89% | -55.5% |
| Q2 2023 | $41,116,799 | +9.2% | 6,526,476 | 0.0% | 17.73% | +26.4% |
| Q1 2023 | $37,657,767 | -43.8% | 6,526,476 | 0.0% | 14.03% | -42.6% |
| Q4 2022 | $66,961,644 | -28.8% | 6,526,476 | +16.0% | 24.44% | -43.2% |
| Q3 2022 | $94,075,000 | +19.4% | 5,626,476 | 0.0% | 43.01% | +11.6% |
| Q2 2022 | $78,771,000 | -13.3% | 5,626,476 | 0.0% | 38.55% | -17.1% |
| Q1 2022 | $90,868,000 | -24.6% | 5,626,476 | 0.0% | 46.52% | -31.7% |
| Q4 2021 | $120,463,000 | – | 5,626,476 | – | 68.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 2,732,501 | $81,702,000 | 7.97% |
| Cormorant Asset Management, LP | 5,114,850 | $146,409,000 | 3.26% |
| Octagon Capital Advisors LP | 250,000 | $7,475,000 | 2.82% |
| EcoR1 Capital, LLC | 1,137,940 | $34,024,000 | 1.51% |
| RA Capital Management | 2,186,636 | $65,380,000 | 0.99% |
| Avoro Capital Advisors LLC | 1,468,318 | $39,702,000 | 0.69% |
| Vivo Capital, LLC | 530,991 | $15,877,000 | 0.56% |
| Rock Springs Capital Management LP | 327,250 | $9,785,000 | 0.21% |
| Artal Group S.A. | 400,000 | $11,960,000 | 0.21% |
| Baker Brothers Advisors | 1,436,636 | $42,955,000 | 0.19% |